Is Shanmuga Hos. overvalued or undervalued?

As of 19 November 2025, the valuation grade for Shanmuga Hospitals has moved from very attractive to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios include a PE ratio of 14.42, an EV to EBITDA of 8.10, and a ROCE of 12.75%.
In comparison to its peers, Shanmuga Hospitals' PE ratio is significantly lower than that of Max Healthcare, which stands at 80.06, and also lower than Apollo Hospitals at 64.09. This suggests that while Shanmuga is overvalued, it is still more attractively priced than some of its competitors. Despite a recent one-week stock return of 4.57% compared to the Sensex's 0.85%, the overall valuation metrics indicate that investors should approach Shanmuga Hospitals with caution.